Of these, genes such as NFATC1, which is an oncogene57 and ACKR3 (6719 and 6721 degrees/links respectively), which is involved in tumour development and metastasis in many tumours58, are recognized as potential therapeutic targets. This evidence concerns the gene ACKR3 and neoplasm.